Morgan Sindall Professional Services (MSPS) has won a significant contract for a world-leading life sciences business to support the design and build of a new, best-in-class production facility for completion in 2015.
Rayner Intraocular Lenses, whose products have been used to surgically restore the sight of millions of people worldwide, are building a new facility to meet global demand. MSPS is providing the civil and structural, process, mechanical and electrical, architectural, BREEAM and CDM services for the new development.
The consultancy, which has designed over 2 million sq ft of clean room space over the past 20 years, was tasked with developing options for the refurbishment of an alternative building as well as the selected option of a new, highly-efficient facility.
The new brownfield development is close enough to Rayner’s existing facility to retain its highly skilled, specialized workforce and the consultancy will support a phased occupation to take place, ensuring no interruption to production.
Mark Dickson, director for manufacturing and life sciences says that MSPS was chosen for its leading experience in complex manufacturing: “We have delivered a design that makes intelligent use of internal space to ensure increased output and a reduction in operating costs. Our design goes beyond building regulations to reduce energy consumption, which is detailed on a per lens basis,” he explains.
“The facility is designed to achieve BREEAM ‘very good’ status for the low carbon technology used in the facility.”
Good Manufacturing Practice (GMP) is key to the design of the new facility, and integral to all aspects of the building including its use of space, operation, the materials used and their cleaning and maintenance.
MSPS’ front-end engineering and process skills were employed to develop User Requirement Specifications (URS) and the multidisciplinary design solution was developed in a BIM environment, co-ordinated through Revit in order that MSPS could clearly and visually communicate the design’s attributes and benefits.
Part of the process engineering consultation was in the design of bespoke equipment; MSPS’ role was to identify the equipment specification and effectively translate these detailed and exacting requirements to the supplying vendors. This equipment will deliver the greatest efficiency and benefits to the business’ production.
Martin Jamieson, Rayner CEO commented that implantable medical devices are subject to rigorous technical and quality standards, imposed by the regulatory authorities around the world: “In partnership with MSPS Rayner will deliver a state-of-the-art manufacturing facility producing intraocular lenses for sale to markets worldwide. The decision to base the facility in the UK is a tribute to the quality and productivity leap that will be achieved in this country. Rayner will also move its global headquarters to the new facility.”
The detail design phase will be completed in early 2014, allowing the start of construction, which is due for completion in October 2015.
Rayner Intraocular Lenses is the only manufacturer of intraocular lenses in the UK. The company is a member of the Rayner group of companies which has had interests in optics since it was established in 1910.
Having predicted reaching maximum production capacity in its existing facility, Rayner put out to tender a brief that would future proof its production capabilities.